Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ZYDUS PHARMS

  • FDA Approval
  • Jan. 26, 2024, 09:45 UTC
  • 32
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

BRECKENRIDGE PHARM

  • FDA Approval
  • Jan. 25, 2024, 19:54 UTC
  • 34
  • 0 comments

FDA approve RIVAROXABAN

Comment Full text

LUPIN LTD

  • FDA Approval
  • Jan. 25, 2024, 19:41 UTC
  • 31
  • 0 comments

FDA approve ROPIVACAINE HYDROCHLORIDE

Comment Full text

ASTRAZENECA

  • FDA Approval
  • Jan. 25, 2024, 15:19 UTC
  • 39
  • 0 comments

FDA approve SELUMETINIB SULFATE

Comment Full text

MILLA PHARMS

  • FDA Approval
  • Jan. 24, 2024, 09:46 UTC
  • 30
  • 0 comments

FDA approve SODIUM ACETATE

Comment Full text

PAR PHARM INC

  • FDA Approval
  • Jan. 24, 2024, 09:46 UTC
  • 29
  • 0 comments

FDA approve VARENICLINE TARTRATE

Comment Full text

TORRENT

  • FDA Approval
  • Jan. 24, 2024, 09:46 UTC
  • 30
  • 0 comments

FDA approve FLUPHENAZINE HYDROCHLORIDE

Comment Full text

UNICHEM

  • FDA Approval
  • Jan. 24, 2024, 09:46 UTC
  • 33
  • 0 comments

FDA approve VALSARTAN

Comment Full text

LAURUS

  • FDA Approval
  • Jan. 24, 2024, 05:11 UTC
  • 33
  • 0 comments

FDA approve ATORVASTATIN CALCIUM

Comment Full text

BIONPHARMA

  • FDA Approval
  • Jan. 24, 2024, 05:11 UTC
  • 29
  • 0 comments

FDA approve FLUVOXAMINE MALEATE

Comment Full text
  • Previous
  • 567
  • 568
  • 569
  • 570
  • 571
  • Next

Search

News categories

  • Technical Exchange News(11766)
  • Event(4289)
  • SEC News(235890)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143348)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin